World Trade Organization (WTO) members unveiled a new package of trade accords late Thursday following a marathon negotiating session in Geneva, Switzerland, headlined by deals to create flexible intellectual property rules covering COVID-19 vaccines, as well as other trade issues such as global fishing subsidies.
Under an arrangement known as compulsory licensing, member countries agreed to a vaccine patent waiver as a way to boost supplies of COVID-19 shots to lower income countries.
The debate overcame a protracted fight between the USA and China over the Biden administration’s demand that China be clearly excluded from the deal – for fear that it would enable China to steal US technologies.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze